For individuals with Type 2 Diabetes, where elevated blood glucose levels are common, GLP-1 and GLP-2 effectively reduces these levels
Observed effects in human trials Reported adverse events across the IV and oral trials included headache, fatigue, dizziness, nasopharyngitis, diarrhea, flatulence, increased appetite, nausea, and back pain
Understanding blood work changes on the compound Semaglutide therapy produces measurable changes in blood work that both you and your provider should monitor
The risk increases in patients with MTHFR gene variants (which impair methylation efficiency) or those already consuming high-dose methionine supplements
23, 2025 Pennsylvania SB271 and "Pennsylvania HB1470" BillTrack50